Voyager Therapeutics Inc (VYGR)

전일 마감가:

$8.57

열려 있는:

$8.65

하루 거래량:

651.61K

시가총액:

$469.37M

수익:

$250.01M

순이익/손실:

$132.33M

주가수익비율:

3.8018

EPS:

2.27

순현금흐름:

$74.66M

1주 성능:

+2.25%

1개월 성능:

+8.15%

6개월 성능:

+31.76%

1년 성능:

-24.07%

1일 변동 폭

$8.30

$8.77

52주 변동 폭

$6.06

$14.34

Voyager Therapeutics Inc Stock (VYGR) Company Profile

명칭

Voyager Therapeutics Inc

부문

Healthcare (1211)

산업

Biotechnology (697)

전화

857-259-5340

주소

75 Sidney Street, Cambridge, MA

직원

88

트위터

@VoyagerTx

다음 수익 날짜

2024-06-05

최신 SEC 제출 서류

VYGR's Discussions on Twitter

Voyager Therapeutics Inc Stock (VYGR) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2023-05-10	개시	Truist	Buy
2023-03-10	개시	Oppenheimer	Outperform
2021-10-07	업그레이드	Robert W. Baird	Neutral → Outperform
2021-02-26	다운그레이드	Robert W. Baird	Outperform → Neutral
2021-02-03	다운그레이드	BTIG Research	Buy → Neutral
2021-02-03	다운그레이드	Wedbush	Outperform → Neutral
2020-12-24	다운그레이드	Cantor Fitzgerald	Overweight → Neutral
2020-12-23	다운그레이드	Raymond James	Outperform → Mkt Perform
2020-11-11	다운그레이드	Oppenheimer	Outperform → Perform
2020-11-10	다운그레이드	Raymond James	Strong Buy → Outperform
2020-11-10	다운그레이드	Wells Fargo	Overweight → Equal Weight
2020-03-19	개시	The Benchmark Company	Buy
2020-02-06	개시	Oppenheimer	Outperform
2018-11-15	업그레이드	Raymond James	Outperform → Strong Buy
2018-09-10	재개	BTIG Research	Buy
2018-09-10	다운그레이드	Morgan Stanley	Overweight → Equal-Weight
2018-06-04	개시	H.C. Wainwright	Buy
2018-03-12	다운그레이드	Evercore ISI	Outperform → In-line
2018-03-12	다운그레이드	Wedbush	Outperform → Neutral
2018-02-02	개시	Morgan Stanley	Overweight
2017-11-28	재개	Piper Jaffray	Overweight
2017-10-31	개시	Robert W. Baird	Outperform
2017-10-27	개시	Canaccord Genuity	Buy
2017-10-23	재확인	Stifel	Buy
2017-10-12	개시	Raymond James	Outperform
2017-08-17	개시	Evercore ISI	Outperform
2017-07-28	재개	Stifel	Buy

모두보기

Voyager Therapeutics Inc 주식(VYGR)의 최신 뉴스

Voyager Therapeutics (NASDAQ:VYGR) Rating Reiterated by HC Wainwright - MarketBeat

MarketBeat

Q2 2024 EPS Estimates for Voyager Therapeutics, Inc. Boosted by Analyst (NASDAQ:VYGR) - MarketBeat

MarketBeat

Wedbush Weighs in on Voyager Therapeutics, Inc.'s Q2 2024 Earnings (NASDAQ:VYGR) - Defense World

Defense World

Voyager Therapeutics Announces First Participants Dosed in Single Ascending Dose Trial of VY-TAU01 for the ... - GlobeNewswire

GlobeNewswire

Voyager Therapeutics Announces First Participants Dosed in Single Ascending Dose Trial of VY-TAU01 for the Treatment of Alzheimer’s Disease

GlobeNewswire Inc.

Voyager's journey to identify a new shuttle mechanism to bring gene therapies into the brain - BioCentury

BioCentury

Voyager Therapeutics Inc (VYGR) 재무 분석

Voyager Therapeutics Inc (VYGR) 매출 2024

Voyager Therapeutics Inc (VYGR) 순이익 2024

Voyager Therapeutics Inc (VYGR) 현금흐름 2024

Voyager Therapeutics Inc (VYGR) 주당 순이익 2024